Dr. Hellerstedt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2410 Round Rock Ave
Ste 150
Round Rock, TX 78681Phone+1 512-341-8724Fax+1 512-687-0295
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2000 - 2003- University of MichiganResidency, Internal Medicine, 1997 - 2000
University of Pittsburgh School of MedicineClass of 1997
Certifications & Licensure
TX State Medical License 2003 - 2026
MI State Medical License 2000 - 2004- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
- S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsIncidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With LetrozoleLea Krekow, Beth A. Hellerstedt, Rufus P. Collea, Steven Papish, Shrinivas M. Diggikar
Journal of Clinical Oncology. 2016-09-27 - 284 citationsThe Current State of Hormonal Therapy for Prostate CancerBeth A. Hellerstedt, Kenneth J. Pienta
CA. 2002-05-01 - 207 citationsPhase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast CancerJoyce O'Shaughnessy, Lee S. Schwartzberg, Michael A. Danso, Kathy D. Miller, Hope S. Rugo
Journal of Clinical Oncology. 2014-10-27
Journal Articles
- Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung CarcinomaBeth A Hellerstedt, Nicholas J Vogelzang, Harriet M Kluger, Christopher A Yasenchak, Michael S Gordon, Primo Lara, Clinical Lung Cancer
Authored Content
- Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung CarcinomaOctober 2018
Press Mentions
Austin’s Top Doctors 2021December 21st, 2020- Dr. Beth Hellerstedt: Personalizing Breast Cancer Care During COVID-19October 19th, 2020
- Breast Cancer Awareness Month: Living with Metastatic Breast CancerOctober 14th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
